IL15 and neoplasm: In addition, a second intratumoral delivery of IL-15 complexes may improve penetrance throughout the tumor, and it is possible that double treatment provides enough IL-15 complexes throughout the TME and extends time under treatment compared to a single dose; thus, enhancing the antitumor immune response and overall efficacy.